{
  "slug": "delineate",
  "name": "Delineate",
  "yc_id": 29988,
  "batch": "Winter 2025",
  "website": "https://delineate.pro/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:34:00.653316",
    "website": "https://delineate.pro/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 2854.65,
      "final_url": "https://www.delineate.pro/",
      "redirected": true,
      "checked_at": "2025-10-17T01:34:03.507974"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "delineate.pro",
      "error": "Whois command returned no output"
    },
    "social_links": {
      "twitter": null,
      "linkedin": null,
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": false,
      "content_security_policy": false,
      "x_frame_options": false,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 0,
      "server": "openresty"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:42:14.452235",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0-claude",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T10:52:15.622947",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "AI adoption in pharma R&D",
        "Increasing clinical trial costs and complexity",
        "Regulatory push for faster drug approvals"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Specialized clinical trial datasets and domain expertise in pharmaceutical workflows",
      "differentiation": "AI agents specifically designed for clinical trial optimization rather than general pharma AI",
      "competitive_advantages": [
        "Early partnerships with major pharma companies",
        "Specialized dataset creation capabilities"
      ],
      "competitive_vulnerabilities": [
        "Large tech companies entering pharma AI",
        "Established clinical research organizations with existing relationships"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Partnerships with two major pharmaceutical companies",
        "Large addressable market with high value per day saved"
      ],
      "growth_bottlenecks": [
        "Long pharma sales cycles",
        "Regulatory compliance requirements"
      ]
    },
    "risk_analysis": {
      "market_risk": "low",
      "technology_risk": "medium",
      "execution_risk": "medium",
      "overall_risk_score": 6,
      "key_risks": [
        "Regulatory changes in clinical trial requirements",
        "Competition from established pharma tech vendors",
        "Dependency on AI model accuracy for critical decisions"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Massive market with clear ROI proposition",
        "Early traction with enterprise customers",
        "High switching costs once integrated"
      ],
      "concerns": [
        "Competitive landscape with well-funded players",
        "Complex regulatory environment"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Veracyte",
        "Tempus",
        "Flatiron Health"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Expand pilot programs with existing pharma partners",
        "Build regulatory compliance expertise"
      ],
      "expansion_opportunities": [
        "Biotech companies beyond big pharma",
        "International markets with different regulatory frameworks"
      ]
    },
    "tokens_used": {
      "input": 725,
      "output": 541,
      "total": 1266,
      "estimated_cost": 0.01029
    },
    "status": "success"
  },
  "phase8_complete": true
}